Skip to main content
TipRanks
Go Ultimate75% OFF

Basilea Pharmaceutica (BPMUF) Q2 2022 Earnings Report

0 Followers

BPMUF Q2 2022 EPS Results

Actual EPS
-$1.23
Consensus EPS
-$1.55
Beat/Miss
Beat by +$0.32
One Year Ago EPS
-$2.20

BPMUF Q2 2022 Revenue Results

Actual Revenue
$70.21M
Expected Revenue
$42.40M
Beat/Miss
Beat by +$27.81M
YoY Revenue Growth
+8.21%

Earnings Announcement Details

Quarter
Q2 2022
Date
08/16/2022
Time
Before Open
Conference Call
Tuesday, August 16, 2022
BPMUF Upcoming Earnings

Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

BPMUF Earnings History

BPMUF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)7.09-2.38――
Aug 18, 20262026 (Q2)4.002.551.5169.05% (+1.04)
Feb 17, 20262025 (Q4)1.962.385.63-57.70% (-3.25)
Aug 19, 20252025 (Q2)2.431.511.89-20.00% (-0.38)
Feb 18, 20252024 (Q4)3.885.63-2.04375.66% (+7.67)
Aug 13, 20242024 (Q2)1.401.892.91-35.21% (-1.02)
Feb 13, 20242023 (Q4)-2.41-2.042.45-183.17% (-4.50)
Aug 15, 20232023 (Q2)0.962.91-1.23336.02% (+4.14)
Feb 14, 20232022 (Q4)-1.562.451.5162.70% (+0.95)
Aug 16, 20222022 (Q2)-1.55-1.23-2.244.02% (+0.97)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed